Form 4: VolitionRx Chief Commercial Officer Reports Routine Stock Transaction for Tax Withholding

VolitionRx's Chief Commercial Officer, Gael Forterre, reported a disposition of 1,996 shares of common stock to satisfy tax withholding obligations related to restricted stock unit settlement.

Summary

• Gael Forterre, Chief Commercial Officer of VolitionRx Ltd. (VNRX), reported a transaction involving company common stock.
• On June 1, 2025, 1,996 shares of common stock were disposed of at a price of $0.7679 per share.
• This disposition was a 'tax withholding' transaction (Code F), where VolitionRx retained shares to cover tax obligations arising from the settlement of 4,828 restricted stock units (RSUs).
• The RSUs were awarded to Mr. Forterre in lieu of cash compensation.
• No shares were sold by Mr. Forterre or VolitionRx in the open market as part of this transaction.
• Following the transaction, Mr. Forterre directly beneficially owns 159,466 shares of common stock.
• Additionally, he indirectly beneficially owns 5,000 shares through his spouse and 32,500 shares through Armorica Partners, LLC, an entity he manages and controls.

Sentiment

Score: 5

Explanation: Neutral. The document reports a routine insider transaction for tax withholding purposes, which is a standard part of executive compensation and not indicative of positive or negative company performance or insider sentiment regarding the stock.

Positives

• The transaction represents the settlement of previously awarded restricted stock units, indicating compensation for the Chief Commercial Officer.
• The disposition was solely for tax withholding purposes, not an open market sale by the insider, which is a routine administrative event.

Negatives

• A reduction in the direct beneficial ownership of common stock by the Chief Commercial Officer due to tax withholding.

Future Outlook

NA

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction and does not provide information relevant to broader industry trends or competitive analysis.

Related Party Transactions

• Gael Forterre indirectly beneficially owns 32,500 shares through Armorica Partners, LLC, an entity he manages and controls. He disclaims beneficial ownership of these shares except to the extent of his pecuniary interest.

Stakeholder Impact

• Shareholders: The transaction is a routine tax withholding and does not directly impact the company's operations or financial health, but it slightly reduces the direct shareholding of a key executive. The total beneficial ownership (direct and indirect) remains substantial.

Key Dates

Keywords

VolitionRx, VNRX, Gael Forterre, Insider Transaction, Form 4, Stock Ownership, Restricted Stock Units, Tax Withholding, Officer Compensation